News & Updates

Show Multimedia Only

Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE

09 Feb 2023

Young patients with newly diagnosed systemic lupus erythematosus (SLE) are vulnerable to psychiatric comorbidity, which tends to increase healthcare utilization, according to a study.

09 Feb 2023

Anti-MDA5 antibody–positive dermatomyositis with anti-Ro52 ups ILD, mortality risks

09 Feb 2023

Patients with dermatomyositis (DM) who are positive for antimelanoma differentiation-associated gene 5 antibody (anti-MDA5) are more likely to have anti-Ro52 antibodies as well, and such coexistence appears to heighten the risks of rapidly progressive interstitial lung disease (ILD) and mortality, suggests a recent study.

09 Feb 2023

Biologic agents raise IBD risk among axSpA patients

08 Feb 2023

Based on observational studies, patients with axial spondyloarthritis (axSpA) treated with biologics are at higher risk of inflammatory bowel disease (IBD), while findings from randomized controlled trials (RCTs) suggest that treatment with etanercept (ETN) tends to increase such risk compared to other antitumour necrosis factor (anti-TNF) therapies, according to the result of a meta-analysis.

08 Feb 2023

Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals

06 Feb 2023 by

A collaborative clinic led by a pharmacist helps patients with gout to attain better clinical outcomes in the management of their condition, even in the presence of renal impairment, reports a Singapore study. The clinic provides safe, stepwise increments of urate-lowering therapy (ULT) in addition to serum uric acid (SUA) monitoring and adherence reinforcement through frequent initial visits.

06 Feb 2023

Tigulixostat for lowering uric acid scores high in phase II trial

01 Feb 2023

Treatment with the nonpurine xanthine oxidase inhibitor tigulixostat leads to a significant reduction in serum uric acid (sUA) levels while having an acceptable safety profile, as shown in data from the multicentre, double-blind, parallel-group, dose-finding phase II CLUE trial.

01 Feb 2023

Drinking tied to RA disease activity

01 Feb 2023 by

Alcohol consumption appears to influence outcomes in patients with rheumatoid arthritis (RA), with a recent study showing that low to moderate drinkers have a lower disease activity and higher health-related quality of life than abstainers.

01 Feb 2023

$Abatacept shows promise in refractory juvenile dermatomyositis$

Abatacept shows promise in refractory juvenile dermatomyositis

30 Jan 2023

Some patients with treatment-refractory juvenile dermatomyositis (JDM) appear to respond to abatacept, as shown in a small study.

30 Jan 2023

High uric acid levels linked to atrial fibrillation risk

18 Jan 2023

Elevated uric acid concentration appears to contribute to an increased risk of atrial fibrillation (AF) regardless of the presence of cardiovascular disease and cardiovascular risk factors, according to a study.

18 Jan 2023